Insider Transactions Reported by 15 Insiders of Context Therapeutics Inc.

Symbol
CNTX on Nasdaq
Location
Philadelphia, PA

Insiders trading volume in the past year

Context Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Martin A. Lehr Chief Executive Officer, Director $769,435 +$70,080 +10% 09 Jun 2025
Alex Levit Chief Legal Officer, Corp. Sec $58,030 +$11,520 +25% 06 Jun 2025
Jennifer Lynn Minai-Azary Chief Financial Officer $50,966 +$25,486 +100% 06 Jun 2025
Tarek Sahmoud Chief Medical Officer $8,415 16 Aug 2022
Jennifer Evans Stacey Director 12 Jun 2025
Linda West Director 12 Jun 2025
Philip W. Kantoff Director 12 Jun 2025
Ullmann Claudio Dansky Chief Medical Officer 13 Feb 2025
William F. Rencher Former Section 16 officer 15 Feb 2022
Evan G. Dick Former Section 16 officer 15 Feb 2022
Karen Deborah Chagin Chief Medical Officer 09 Jun 2025
RICHARD J. BERMAN Director 13 Jun 2024
Luke Walker Director 12 Jun 2025
Karen L. Smith Director 12 Jun 2025
Andy Pasternak Director 12 Jun 2025

Recent Insider Transactions by Companies or Individuals for Context Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.